DK113643B - Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser.

Info

Publication number
DK113643B
DK113643B DK613465AA DK613465A DK113643B DK 113643 B DK113643 B DK 113643B DK 613465A A DK613465A A DK 613465AA DK 613465 A DK613465 A DK 613465A DK 113643 B DK113643 B DK 113643B
Authority
DK
Denmark
Prior art keywords
compounds
preparation
therapeutically effective
acid addition
addition salts
Prior art date
Application number
DK613465AA
Other languages
English (en)
Inventor
Hoechst Ag F
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK113643B publication Critical patent/DK113643B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK613465AA 1964-12-03 1965-11-29 Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser. DK113643B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0044603 1964-12-03

Publications (1)

Publication Number Publication Date
DK113643B true DK113643B (da) 1969-04-14

Family

ID=7100094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK613465AA DK113643B (da) 1964-12-03 1965-11-29 Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser.

Country Status (10)

Country Link
US (1) US3426028A (da)
AT (5) AT263013B (da)
BE (1) BE673267A (da)
CH (1) CH464917A (da)
DE (1) DE1445787A1 (da)
DK (1) DK113643B (da)
FR (2) FR1477462A (da)
GB (1) GB1124661A (da)
NL (1) NL6515412A (da)
SE (1) SE319476B (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880211A (en) * 1959-03-31 Chcoochj
US2741619A (en) * 1951-11-07 1956-04-10 Sterling Drug Inc Alkyl 1-alkyl-4-cyclohexylpiperidine-4-carboxylates and their synthesis
US2858316A (en) * 1956-11-16 1958-10-28 Union Chimique Belge Sa New piperidine derivatives

Also Published As

Publication number Publication date
AT263012B (de) 1968-07-10
CH464917A (de) 1968-11-15
AT260932B (de) 1968-03-25
DE1445787A1 (de) 1969-01-23
AT260933B (de) 1968-03-25
AT263013B (de) 1968-07-10
BE673267A (da) 1966-06-03
US3426028A (en) 1969-02-04
FR1477462A (fr) 1967-04-21
NL6515412A (da) 1966-06-06
SE319476B (da) 1970-01-19
FR5492M (da) 1967-10-30
AT260929B (de) 1968-03-25
GB1124661A (en) 1968-08-21

Similar Documents

Publication Publication Date Title
DK114981B (da) Fremgangsmåde til fremstilling af basisk substituerede phthalaner eller iso-chromaner eller syreadditionssalte deraf.
DK113295B (da) Fremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK107288C (da) Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf.
DK116362B (da) Fremgangsmåde til fremstilling af basisk substituerede benzothiazepinderivater eller syreadditionssalte deraf.
DK114618B (da) Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf.
DK114974B (da) Fremgangsmåde til fremstilling af quinolinderivater eller syreadditionssalte deraf.
DK126592B (da) Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf.
DK117637B (da) Fremgangsmåde til fremstilling af et octapeptidderivat eller syreadditionssalte deraf.
DK117835B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme N-4-pyrimidinyl-anthranilsyreforbindelser eller salte deraf.
DK109805C (da) Fremgangsmåde til fremstilling af basisk substituerede 2-oxobenzimidazoliner eller syreadditionssalte deraf.
DK122327B (da) Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf.
DK117636B (da) Fremgangsmåde til fremstilling af diazocin- eller diazecinderivater eller syreadditionssalte deraf.
DK106335C (da) Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf.
DK107875C (da) Fremgangsmåde til fremstilling af heterocykliske sulfonylcarbaminsyrederivater eller syreadditionssalte deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK115842B (da) Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf.
DK111072B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK124614B (da) Fremgangsmåde til fremstilling af 3-(3-piperidino- eller morpholinopropionyl)-5-phenylisoxazolderivater eller syreadditionssalte deraf.
DK107485C (da) Fremgangsmåde til fremstilling af basiske phenanthrenderivater eller syreadditionssalte deraf.
DK113643B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme piperidinderivater eller syreadditionssalte af disse forbindelser.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK129936B (da) Fremgangsmåde til fremstilling af lincomycinforbindelser eller syreadditionssalte deraf.
DK107353C (da) Fremgangsmåde til fremstilling af indolderivater eller syreadditionssalte deraf.
DK115181B (da) Fremgangsmåde til fremstilling af xylitolnicotinater eller syreadditionssalte deraf.
DK107873C (da) Fremgangsmåde til fremstilling af phenthiazinderivater eller syreadditionssalte deraf.